Ralph S. Baric: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Filling in 2 references using Reflinks
format refs
Line 7: Line 7:
'''Ralph S Baric''' (born 1954) is [[William R. Kenan Jr.]] Distinguished Professor in the Department of Epidemiology, and Professor in the Department of Microbiology and Immunology at the [[The University of North Carolina at Chapel Hill]].
'''Ralph S Baric''' (born 1954) is [[William R. Kenan Jr.]] Distinguished Professor in the Department of Epidemiology, and Professor in the Department of Microbiology and Immunology at the [[The University of North Carolina at Chapel Hill]].


Baric's work involves coronaviruses.<ref>{{cite web|url=https://www.msnbc.com/the-beat-with-ari/watch/coronavirus-cure-hear-from-top-scientist-who-spent-years-devising-cure-for-covid-19-80730181693 |title=Hear from top scientist who has spent 'years' working toward a cure for coronaviruses |publisher=Msnbc.com |date= |accessdate=2021-02-13}}</ref> Baric has warned of emerging coronaviruses presenting as a significant threat to global health, due to [[zoonosis]].<ref>https://www.medscape.com/viewarticle/932020</ref>
Baric's work involves coronaviruses.<ref>{{cite web|url=https://www.msnbc.com/the-beat-with-ari/watch/coronavirus-cure-hear-from-top-scientist-who-spent-years-devising-cure-for-covid-19-80730181693 |title=Hear from top scientist who has spent 'years' working toward a cure for coronaviruses |publisher=Msnbc.com |date= |accessdate=2021-02-13}}</ref> Baric has warned of emerging coronaviruses presenting as a significant threat to global health, due to [[zoonosis]].<ref>{{cite web | last=Schmidt | first=Charles | title=For Experts Who Study Coronaviruses, a Grim Vindication | website=Medscape | date=2020-06-09 | url=http://www.medscape.com/viewarticle/932020 | access-date=2021-02-13}}</ref>


== Early life and education ==
== Early life and education ==
Line 15: Line 15:
== Career ==
== Career ==


Ralph Baric has published multiple articles and book chapters on the epidemiology and genetics of various viruses, including [[Norwalk virus]],<ref>https://www.nature.com/articles/nm860</ref><ref>https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.21237</ref> [[norovirus]],<ref>{{cite web|url=https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0050031 |title=Mechanisms of GII.4 Norovirus Persistence in Human Populations |publisher=Journals.plos.org |date=2008-02-12 |accessdate=2021-02-13}}</ref> and [[coronavirus]]es,<ref>https://www.nature.com/articles/nrmicro3143</ref><ref>https://link.springer.com/chapter/10.1007%2F3-540-26765-4_1</ref><ref>https://jvi.asm.org/content/84/7/3134</ref> as well as potential treatments for viral diseases.<ref>https://www.nature.com/articles/s41467-019-13940-6</ref><ref>https://stm.sciencemag.org/content/9/396/eaal3653</ref>
Ralph Baric has published multiple articles and book chapters on the epidemiology and genetics of various viruses, including [[Norwalk virus]],<ref>{{cite web | title=Human susceptibility and resistance to Norwalk virus infection | website=Nature Medicine | date=2003-04-14 | url=https://www.nature.com/articles/nm860 | access-date=2021-02-13}}</ref><ref>{{cite journal | last=Teunis | first=Peter F.M. | last2=Moe | first2=Christine L. | last3=Liu | first3=Pengbo | last4=E. Miller | first4=Sara | last5=Lindesmith | first5=Lisa | last6=Baric | first6=Ralph S. | last7=Le Pendu | first7=Jacques | last8=Calderon | first8=Rebecca L. | title=Norwalk virus: How infectious is it? | journal=Journal of Medical Virology | publisher=Wiley | volume=80 | issue=8 | year=2008 | issn=0146-6615 | doi=10.1002/jmv.21237 | pages=1468–1476}}</ref> [[norovirus]],<ref>{{cite web|url=https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0050031 |title=Mechanisms of GII.4 Norovirus Persistence in Human Populations |publisher=Journals.plos.org |date=2008-02-12 |accessdate=2021-02-13}}</ref> and [[coronavirus]]es,<ref>{{cite web | title=A decade after SARS: strategies for controlling emerging coronaviruses | website=Nature Reviews Microbiology | date=2013-11-11 | url=https://www.nature.com/articles/nrmicro3143 | access-date=2021-02-13}}</ref><ref>{{cite book | last=Brian | first=D. A. | last2=Baric | first2=R. S. | title=Current Topics in Microbiology and Immunology | chapter=Coronavirus Genome Structure and Replication | publisher=Springer Berlin Heidelberg | publication-place=Berlin, Heidelberg | year=2005 | isbn=978-3-540-21494-6 | issn=0070-217X | doi=10.1007/3-540-26765-4_1 | pages=1–30}}</ref><ref>https://jvi.asm.org/content/84/7/3134</ref> as well as potential treatments for viral diseases.<ref>{{cite web | title=Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV | website=Nature Communications | date=2020-01-10 | url=https://www.nature.com/articles/s41467-019-13940-6 | access-date=2021-02-13}}</ref><ref>{{cite journal | last=Sheahan | first=Timothy P. | last2=Sims | first2=Amy C. | last3=Graham | first3=Rachel L. | last4=Menachery | first4=Vineet D. | last5=Gralinski | first5=Lisa E. | last6=Case | first6=James B. | last7=Leist | first7=Sarah R. | last8=Pyrc | first8=Krzysztof | last9=Feng | first9=Joy Y. | last10=Trantcheva | first10=Iva | last11=Bannister | first11=Roy | last12=Park | first12=Yeojin | last13=Babusis | first13=Darius | last14=Clarke | first14=Michael O. | last15=Mackman | first15=Richard L. | last16=Spahn | first16=Jamie E. | last17=Palmiotti | first17=Christopher A. | last18=Siegel | first18=Dustin | last19=Ray | first19=Adrian S. | last20=Cihlar | first20=Tomas | last21=Jordan | first21=Robert | last22=Denison | first22=Mark R. | last23=Baric | first23=Ralph S. | title=Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses | journal=Science Translational Medicine | volume=9 | issue=396 | date=2017-06-28 | issn=1946-6234 | pmid=28659436 | doi=10.1126/scitranslmed.aal3653 | url=https://stm.sciencemag.org/content/9/396/eaal3653 | access-date=2021-02-13 | page=}}</ref>


In 2015 Ralph Baric published an article titled A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.<ref>https://www.nature.com/articles/nm.3985</ref>
In 2015 Ralph Baric published an article titled A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.<ref>{{cite web | title=A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence | website=Nature Medicine | url=https://www.nature.com/articles/nm.3985 | access-date=2021-02-13}}</ref>


In 2020, Baric contributed to establishing the official nomenclature and taxonomic classification of [[SARS-CoV-2]].<ref>https://www.nature.com/articles/s41564-020-0695-z</ref>
In 2020, Baric contributed to establishing the official nomenclature and taxonomic classification of [[SARS-CoV-2]].<ref>{{cite web | title=The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2 | website=Nature Microbiology | url=https://www.nature.com/articles/s41564-020-0695-z | access-date=2021-02-13}}</ref>


==References==
==References==

Revision as of 23:23, 13 February 2021


Ralph S Baric (born 1954) is William R. Kenan Jr. Distinguished Professor in the Department of Epidemiology, and Professor in the Department of Microbiology and Immunology at the The University of North Carolina at Chapel Hill.

Baric's work involves coronaviruses.[1] Baric has warned of emerging coronaviruses presenting as a significant threat to global health, due to zoonosis.[2]

Early life and education

Career

Ralph Baric has published multiple articles and book chapters on the epidemiology and genetics of various viruses, including Norwalk virus,[3][4] norovirus,[5] and coronaviruses,[6][7][8] as well as potential treatments for viral diseases.[9][10]

In 2015 Ralph Baric published an article titled A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.[11]

In 2020, Baric contributed to establishing the official nomenclature and taxonomic classification of SARS-CoV-2.[12]

References

  1. ^ "Hear from top scientist who has spent 'years' working toward a cure for coronaviruses". Msnbc.com. Retrieved 2021-02-13.
  2. ^ Schmidt, Charles (2020-06-09). "For Experts Who Study Coronaviruses, a Grim Vindication". Medscape. Retrieved 2021-02-13.
  3. ^ "Human susceptibility and resistance to Norwalk virus infection". Nature Medicine. 2003-04-14. Retrieved 2021-02-13.
  4. ^ Teunis, Peter F.M.; Moe, Christine L.; Liu, Pengbo; E. Miller, Sara; Lindesmith, Lisa; Baric, Ralph S.; Le Pendu, Jacques; Calderon, Rebecca L. (2008). "Norwalk virus: How infectious is it?". Journal of Medical Virology. 80 (8). Wiley: 1468–1476. doi:10.1002/jmv.21237. ISSN 0146-6615.
  5. ^ "Mechanisms of GII.4 Norovirus Persistence in Human Populations". Journals.plos.org. 2008-02-12. Retrieved 2021-02-13.
  6. ^ "A decade after SARS: strategies for controlling emerging coronaviruses". Nature Reviews Microbiology. 2013-11-11. Retrieved 2021-02-13.
  7. ^ Brian, D. A.; Baric, R. S. (2005). "Coronavirus Genome Structure and Replication". Current Topics in Microbiology and Immunology. Berlin, Heidelberg: Springer Berlin Heidelberg. pp. 1–30. doi:10.1007/3-540-26765-4_1. ISBN 978-3-540-21494-6. ISSN 0070-217X.
  8. ^ https://jvi.asm.org/content/84/7/3134
  9. ^ "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV". Nature Communications. 2020-01-10. Retrieved 2021-02-13.
  10. ^ Sheahan, Timothy P.; Sims, Amy C.; Graham, Rachel L.; Menachery, Vineet D.; Gralinski, Lisa E.; Case, James B.; Leist, Sarah R.; Pyrc, Krzysztof; Feng, Joy Y.; Trantcheva, Iva; Bannister, Roy; Park, Yeojin; Babusis, Darius; Clarke, Michael O.; Mackman, Richard L.; Spahn, Jamie E.; Palmiotti, Christopher A.; Siegel, Dustin; Ray, Adrian S.; Cihlar, Tomas; Jordan, Robert; Denison, Mark R.; Baric, Ralph S. (2017-06-28). "Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses". Science Translational Medicine. 9 (396). doi:10.1126/scitranslmed.aal3653. ISSN 1946-6234. PMID 28659436. Retrieved 2021-02-13.
  11. ^ "A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence". Nature Medicine. Retrieved 2021-02-13.
  12. ^ "The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2". Nature Microbiology. Retrieved 2021-02-13.

External links